Proteomics-Int

[Proteomics-Int @proteomics_int]

https://t.co/r1aqW4QE5v #promarkerd #diabetes #DKD

[Austrade @Austrade]

In a world-first, #biotech company @proteomics_int has discovered a predictive diagnostic test to help manage one of the complications of #diabetes and a leading cause of death — diabetic kidney disease (DKD). Read more: https://t.co/bn7TQijSs8

[Proteomics-Int @proteomics_int]

Announced at #2018DTM https://t.co/9IoicNxwR0

[Diabetes Technology @DiabetesTechSoc]

We look forward to seeing you at the Diabetes Technology Meeting in Bethesda next week! Use #2018DTM to tweet about the meeting! https://t.co/Upl8AT5aqY

[Proteomics-Int @proteomics_int]

https://t.co/9IoicNxwR0 @diabetestecsoc #2018DTM #diabetes #DKD #kidneydisease #PromarkerD

[David Langsam @biotech_daily]

.@proteomics_int Receives $834k Federal R&D Tax Incentive - subscribe to Biotech Daily https://t.co/4E9331THtC

[David Langsam @biotech_daily]

.@proteomics_int Licences Promarkerd For Spain; Wins WA Gong - subscribe to Biotech Daily https://t.co/4E9331C6C4

[Proteomics-Int @proteomics_int]

https://t.co/0T2Mcib0BI #promarkerD #diabetes #DKD

[Proteomics-Int @proteomics_int]

Aussie test helps 30 million USA diabetic patients #AFR #AustralianFinancialReview #PromarkerD #diabetes

[David Langsam @biotech_daily]

.@proteomics_int Revenue Up 27% To $1.2m, Loss Up 57% To $1.4m - subscribe to Biotech Daily https://t.co/4E9331THtC

[Proteomics-Int @proteomics_int]

https://t.co/XHl1CqPcrw #promarkerD #diabetes

[Proteomics-Int @proteomics_int]

https://t.co/ngh8JeVFlq #ADA2018

[David Langsam @biotech_daily]

.@proteomics_int $3.4m March 31 Options Underwritten - subscribe to Biotech Daily https://t.co/4E9331C6C4

[Proteomics-Int @proteomics_int]

Proteomics International Investing in CPR Pharma Services | 360Dx https://t.co/0WgTxI1QMH

[Proteomics-Int @proteomics_int]

BRIEF-Proteomics International Laboratories Updates On Investment In CPR Pharma Services | Reuters https://t.co/bXAQjlJYCs

[Proteomics-Int @proteomics_int]

Proteomics International Announces Strategic Alliance and Investment in CPR Pharma Services | BioSpace https://t.co/kzCwSiYeY2

[Proteomics-Int @proteomics_int]

Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services https://t.co/NJ36YTQk20

[Proteomics-Int @proteomics_int]

Pharma Letter BRIEF—Proteonomics buys stake in CPR Pharma https://t.co/e1VI6c0NGx

[Proteomics-Int @proteomics_int]

Proteomics International Investing in CPR Pharma Services | GenomeWeb https://t.co/gDSA2o7Wh2

[Proteomics-Int @proteomics_int]

New biomarkers may accurately identify renal disease in type 2 diabetes patients - https://t.co/EEpf9juPgb https://t.co/Lzr2IWJK4r #DKD

[Proteomics-Int @proteomics_int]

#promarkerD best in world featured in DDN https://t.co/SjNMzvoOY3